Selective Serotonin Reuptake Inhibitors.

Dee Lochmann, Tara Richardson
Author Information
  1. Dee Lochmann: Psychiatry and Behavioral Sciences, University of Kansas School of Medicine-Wichita, Wichita, KS, USA. dlochmann@kumc.edu.
  2. Tara Richardson: Psychiatry and Behavioral Sciences, University of Kansas School of Medicine-Wichita, Wichita, KS, USA.

Abstract

The first antidepressants were created by chance but brought the idea that central serotonin agonism produced an antidepressant effect. SSRIs were the first class of psychotropic medications to be rationally designed, meaning that researchers intended to utilize a specific mechanism of action while avoiding adverse effects. In this way, SSRIs were created to be safer and more tolerable than previous antidepressants. SSRIs share many similarities, but differ in terms of pharmacokinetics and effects on CYP450 enzymes, which is detailed in this chapter. Further information will be provided regarding safety, clinical indications/uses, and dosing recommendations.

Keywords

MeSH Term

Antidepressive Agents
Selective Serotonin Reuptake Inhibitors

Chemicals

Antidepressive Agents
Serotonin Uptake Inhibitors

Word Cloud

Created with Highcharts 10.0.0SSRIseffectsfirstantidepressantscreatedserotoninSelectivechancebroughtideacentralagonismproducedantidepressanteffectclasspsychotropicmedicationsrationallydesignedmeaningresearchersintendedutilizespecificmechanismactionavoidingadversewaysafertolerableprevioussharemanysimilaritiesdiffertermspharmacokineticsCYP450enzymesdetailedchapterinformationwillprovidedregardingsafetyclinicalindications/usesdosingrecommendationsSerotoninReuptakeInhibitorsCitalopramEscitalopramFluoxetineFluvoxamineParoxetineRationaldrugdevelopmentreuptakeinhibitorsSertralineSideTolerabilityVilazodoneVortioxetine

Similar Articles

Cited By